Interpace Diagnostics Group Inc. (IDXG)
Symbol Info
Listed Symbol IDXG
Name Interpace Diagnostics Group Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $21,897,000
Latest Fiscal EPS $-0.43
Price Info
21 Day Moving Average $0.8395
21 Day EMA $0.804840
50 Day Moving Average $0.7727
50 Day EMA $0.791170
200 Day EMA $0.871520
200 Day Moving Average 0.891780
52 Week High $1.78
52 Week Low $0.67
52 Week Change $-25.460800
Alpha -0.030853
Beta 2.3004
Standard Deviation 0.344444
R2 0.053697
Periods 60
Share Information
10 Day Average Volume 192,886
20 Day Average Volume 219,153
30 Day Average Volume 233,416
50 Day Average Volume 267,833
Outstanding Shares 38,196,038
Float Shares 35,017,673
Percent Float 91.68%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 35
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 1,220,292
Institute Holdings Percent 26.300000
Institute Sold Previous 3 Months 786,455
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months -
Insider Holdings Percent 8.30%
Insider Sold Previous 3 Months -
Insiders Shares Owned 3,178,365
Price Change
7 Day Price Change $-0.0797
7 Day Percent Change -9.49%
21 Day Price Change $-0.1255
21 Day Percent Change -14.17%
30 Day Price Change $-0.0547
30 Day Percent Change -6.71%
Month To Date Price Change $-0.1097
Month To Date Percent -12.61%
90 Day Price Change $0.043200
90 Day Percent Change 6.02%
Quarter To Date $0.035300
Quarter To Date Percent 4.87%
180 Day Price Change $-0.1742
180 Day Percent Change -18.64%
200 Day Price Change $-0.1397
200 Day Percent Change -15.52%
Year To Date $-0.0397
Year To Date Percent -4.96%
Profile
Description Interpace Diagnostics Group Inc is a United States-based integrated commercial and bioinformatics company. It is engaged in developing and commercializing molecular diagnostic tests, leveraging the technology and personalized medicine for patient diagnosis and management. The company has four commercialized molecular tests, PancraGen for the diagnosis and prognosis of pancreatic cancer from pancreatic cysts, ThyGenX, for the diagnosis of thyroid cancer from thyroid nodules utilizing a next-generation sequencing assay and, ThyraMIR for the diagnosis of thyroid cancer from thyroid nodules utilizing a proprietary gene expression assay, and RespriDX for assessing metastatic versus primary lung cancer tumors. The company's customers consist of physicians, hospitals, and clinics.
Details
Issue Type CS
Market Cap $29,040,448
Sec Type EQS
Auditor BDO USA, LLP
Total Shares Outstanding 38,196,038
CEO Jack E. Stover
Employees 89
Last Audit UE
Classification
CIK 0001054102
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS Testing Laboratories(541380)
Info
Address 300 Interpace Parkway
Building C
Parsippany, NJ 7054
Website http://www.interpacediagnostics.com
Facisimile +1 973 265-0191
Telephone +1 855 776-6419
Email jgreen@edisongroup.com
Key Ratios
Profitability
EBIT Margin -56.8
EBITDA Margin -42.1
Pre-Tax Profit Margin -136.8
Profit Margin Cont -66.36
Gross Margin 53.80
Profit Margin TOT -65.86
Income Statements
Revenue $23,867,000
Revenue Per Share $0.6249
Revenue 3 Years $-
Revenue 5 Years $-25.05
Valuation Measures
PE Ratio -
Enterprise Value $24,288,063
Price To Sales 1.216762
Price To Free Cash -2.4
PE High Last 5 Years -
Price To Book 0.9
Price To Cash Flow 48.5
PE Low Last 5 Years -
Price To Tangible Book 11.0
Financial Strength
Total Debt To Equity 0.1
Int Coverage -46.8
Current Ratio 1.7
Leverage Ratio 1.5
Quick Ratio 1.6
Long Term Debt To Capital 0.05
Assets
Receivables Turnover 1.4
Invoice Turnover -
Assets Turnover 0.20
Management Effectiveness
Return Assets -30.91
Return On Equity -45.31
Return On Capital -42.48
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
IDXG
Interpace ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.